Traditional-And-Black-Ginger-Biomedicines (Tabgbm)’ May Be Act as ‘Notable-Universal-Preventive-Emergency-Vaccine (Nupev)’ Against 'Future-A to Z-Diseases (Fazd)’ Enriched ‘Clinical-Case-Reports-Medical-Science-Technology-Communication-Research-Innov

research article | DOI: https://doi.org/10.31579/2690-8816/052

Traditional-And-Black-Ginger-Biomedicines (Tabgbm)’ May Be Act as ‘Notable-Universal-Preventive-Emergency-Vaccine (Nupev)’ Against 'Future-A to Z-Diseases (Fazd)’ Enriched ‘Clinical-Case-Reports-Medical-Science-Technology-Communication-Research-Innov

  • Subhas Chandra Datta 1*
  • Ranjan Mukherjee 2

1 PhD & Research from Department of Zoology, VisvaBharati, Santiniketan-731235, and Headmaster & Secretary & Coordinator, Kanchannagar D.N. Das High School (HS), Kanchannagar, Burdwan-713102, Burdwan Municipality, Purba Bardhaman, West Bengal, India.
2 District Coordinator of Sishu Sathi Scheme at Department of Health and Family Welfare, Burdwan-713101, Purba Bardhaman, West Bengal, India 

*Corresponding Author: Dr. Subhas Chandra Datta,. Ph.D. & Research from Department of Zoology,VisvaBharati University, Santiniketan, and Headmaster & Secretary & Coordinator, Kanchannagar D.N.Das High School(HS), Kanchannagar, Burdwan, Municipality, Purba Bardhaman, Burdwan-713

Citation: Subhas Chandra Datta and Ranjan Mukherjee. (2022). Traditional-And-Black-Ginger-Biomedicines (Tabgbm)’ May Be Act As ‘Notable-Universal-Preventive-Emergency-Vaccine (Nupev)’ Against 'Future-A To Z-Diseases (Fazd)’ Enriched ‘Clinical-Case-Reports-Medical-Science-Technology-Communication-Research-Innovation-Global-Health-Ecology-Application (Ccrmstcrighea)!. J. Clinical Research Notes. 3(4); DOI: 10.31579/2690-8816/052

Copyright: © 2022 Subhas Chandra Datta, This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Received: 14 January 2022 | Accepted: 15 February 2022 | Published: 30 April 2022

Keywords: Zingiber; COVID-19; ANOVA

Abstract

Recently, COVID-19 caused mainly by the fast-spreading as compared with primary infections of new variant 'Omicron-SARS-CoV-2, the blind-spots, may have killed nearly 3 million only in India, and the whole world, opening a new chapter that has impacted our lives, and the highest number of Covid-19 deaths due to lack of vaccines gasping for air now. So, it is urgently needed the ‘Universal-Preventive-Emergency-Vaccine for All’ to tackle the awkward situation. Primarily, it has been already observed that the Ginger-MT-biomedicines, prepared from the rhizome of ginger (Zingiber officinale Rosc.), at an extremely-ultra-low-doses, highly effective against coronavirus controlling-COVID-19, and other diseases by increasing natural immunity. Now the aims and objective of the present ‘Notable-Case-Reports (NCR)’ are to see, record, and confirm the efficacy of the ‘High-Diluted-Traditional-Ginger-MT-Biomedicines (HDTGMTBM)’, against naturally occurring coronavirus infections or re-infections of the different-COVID-19-areas of the Burdwan-Municipality, Purba Bardhaman, West Bengal, India. And to highlight novel and significant future aspects of the study with the ‘Black Ginger’, the rhizome of Kaempferia parviflora. As a result in the ‘New-Year-2022; “‘Traditional-And-Black-Ginger-Biomedicines (TABGBM)’ May Be Act As ‘Notable-Universal-Preventive-Emergenc

Vaccine (NUPEV)’ Against 'Future-A to Z-Diseases (FAZD)’ Enriched ‘Clinical-Case-Reports-Medical-Science-Technology-Communication-Research-Innovation-Global-Health-Ecology-Application (CCRMSTCRIGHEA)”. And in near future, both the Ginger MT-Biomedicines may easily tackle many diseases and complications. I will be ‘NUPEV’ due to medicines formulations, very-low-toxicity, potential efficacy, and different phytochemicals, eco-friendly-side-effects-free, cost-effective, easily prepare-able, easily available, easily-manufacture-able, easily-equitable, easily-marketable and easily-supply-able, etc. And in the future, it will be ‘Policy Initiative Potentially Life-Saving 'Future-A to Z-Vaccine for All’.

Introduction

The COVID-19 disease caused by the infection or recinfection of the recent fast-spreading-'Omicron-SARS-CoV-2, the blind-spots, may have killed nearly 3 million only in India, and the whole world, first-time passed one-million per day on an average opening new-chapter in the COVID-19-pandemic, difficult to tackle and tract, and has badly impacted our social lives, education, socioeconomic, etc., and nearly each and every corner of the world, and the highest number of total 850,000 Covid-19 deaths have been reported in the United States, and the rest of the globe have been more than 5.4 million deaths due to lack of vaccines (Figure 1) and we are gasping for air, and this 'Omicron-SARS-CoV-2-wave is different from the previous one, and hot spots from New York to Florida to Texas, generally no need to admit in the intensive care units or ventilation or hospitalized (15%), compared with Delta patients 43 % and 55% Alpha patients, and in India’s major cities are experiencing nearly 50%  or more, 90% in Delhi, increases in cases overnight Omicron attack , just a few months after the deadly Delta attack, and the 15,000 cases in Mumbai reported, and the World Health Organization said that the  Omicron is peaking, and more than half of those in Europe could be infected with Omicron in the next six to eight weeks [1-6]. Now the “Universal-Coronavirus-Vaccines OR the Booster-Vaccine” may be solved the recent crisis [7, 8]. It has been already observed that the biomedicines-Zingiber officinale Rosc. At an extremely ultra-low-dose, prepared from the rhizome of ginger, a promising drug of choice for COVID-19 by increasing natural immunity [9-13]. Still, now, the vaccines were also not equally available globally, as the majority of them were distributed in middle- and high-income countries. So, in the ‘New Year 2022’ preventing shortfalls that impact a global crisis on sustainable development, it has been tried that the global vaccine will be more equitable clinically important ‘Notable-Clinical-Research-Notes’ preventing the bad-wave ‘Omicron’ [14-16]. It is also noted that ginger is a rich source of different bioactive compounds controlling different diseases due to the presence of effective immunity-boosters; antiviral activity against SARS-CoV-2, Influenza virus, Herpes simplex virus, Human respiratory syncytial virus, and hepatitis C virus, etc. [17]. 

The aims and objectives of present studies are to find out or record randomly different clinical cases to see, observe, highlight, and confirm the efficacy as-‘Notable-Clinical-Research-Notes’ with the treatment Ginger MT-biomedicines, prepared from the rhizome (Plate 1) of traditional common ginger (Zingiber officinale Rosc.), at extremely low doses, in the different COVID-19- treatments areas; individual, family, and different community, etc. of the Burdwan Municipality, Purba Bardhaman District, West Bengal, India. And it will be highlighted novel and significant ideas for the future aspects of the study with the ‘Black Ginger’, the rhizome of Kaempferia parviflora, forming the ‘Notable-Universal-Preventive-Emergency-Vaccine (NUPEV)’ Against 'Future-A to Z-Diseases (FAZD)’ in the ‘New Year 2022’ distributing equally, and preventing shortfalls and global crisis, and oath ourselves “Vaccine equity: there is no time to waste” [18].

Materials and Methods

Preparation of High-Diluted Biomedicines Powder 

The high-diluted Ginger MT-Biomedicine (HDGMTBM) was prepared from air-dried powdered (Plate 1) of the ginger rhizomes; Zingiber officinale Rosc., extracting with 90% ethanol, forming residue or high-diluted Ginger MT Biomedicine powder (HDGMTBMP), and the high-diluted-Black-Ginger MT Biomedicine powder (HDBGMTBMP) may be prepared from the rhizomes of Kaempferia parviflora, following same procedure after getting permission from the concerned authority if applicable [9-12, 17, 19-21]. 

Preparation of High-Diluted Biomedicines MT

The high-diluted Ginger MT-Biomedicine (HDGMTBM) was prepared from air-dried powdered rhizomes (Plate 1) of the ginger rhizomes; Zingiber officinale Rosc., extracting with 90% ethanol,  forming residue which was diluted in 90% ethanol at 1mg/ml concentration, and the high-diluted-Black-Ginger MT-Biomedicine (HDBGMTBM) may be prepared from the rhizomes of Kaempferia parviflora, following same procedure after getting permission from the concerned authority if applicable  [9-12,17,19-21]. 

Plate 1: Rhizomes of common ginger (Zingiber officinale Rosc.) and black ginger (Kaempferia parviflora)

Preparation of Ultra-High-Diluted Biomedicines-Liquid (UHDBML) 

The ultra-high-diluted Ginger-Biomedicines-Liquids (UHDGBML); Ginger 30C, Ginger 200C, and Ginger 1000C, were prepared from a few drops of a liquid potency of Ginger 30C, Ginger 200C, and Ginger 1000C, and ultra-high-diluted Black-Ginger-Biomedicines-Liquids (UHDBGBML); maybe prepared Black-Ginger 30C, Black-Ginger 200C, and Black-Ginger 1000C, following same procedure after getting permission from the concerned authority if applicable [9-12,17,19-21]. 

Preparation of Ultra-High-Diluted Biomedicines-Globules (UHDBMG) 

The ultra-high-diluted Ginger-Biomedicines-Globules (UHDGBMG); Ginger 30C, Ginger 200C, and Ginger 1000C, were prepared by soaking the few drops of a liquid potency in the proportion of 7.2 mg globules/ml of Ginger 30C, Ginger 200C, and Ginger 1000C, and following same procedure ultra-high-diluted Black-Ginger-Biomedicines-Globules (UHDBGBMG); Black-Ginger 30C, Black-Ginger 200C, and Black-Ginger 1000C were prepared [9-12,17,19-21]. 

Samples 

The samples were the different individual members, family members, and community members as samples of COVID-19 patients of the containment zones or infected zone or reinfected zones of the Burdwan Municipality as well as Purba Bardhaman District [9-12, 15-54].

Treatments Sample Groups and Duration 

The treated samples were the general patients of the (I)-‘Burdwan Medical College and Hospital (BMCH), coming from different areas of Purba Bardhaman District and the outsider of adjacent District as well as another state also, different COVID-19-patients of (II)-‘Containment Areas’ (CA) of Purba Bardhaman District,  students, parents/guardians, and family members of (III)-‘Kanchannagar D.N. Das High School (HS)’ (KDNDHS), Kanchannagar, Burdwan Municipality, Purba Bardhaman, West Bengal, India from the onset of COVID-19, March 2020 to the end of fast-spreading of COVID-19, December 2021 [9-12,17,19-21]. 

Assistance of Treatments 

Under the instruction of the Hon’ble District Magistrate of Purba Bardhaman, and under the assistance of the Hon’ble Chief Medical Officer, Burdwan Medical College and Hospital and (BMCH AND CMOH) providing the rapid antigen kits for the COVID-19 infected and comorbid patients, the treatments and visits were done at random in the different sample areas  by the Hon’ble treating doctors of ; Dr. Dipanwita Malick, MBBS, and eminent Senior Consultant Physician, Dr. Ranjan Mukherjee, M.B.B.S., M.D., District Coordinator of Sishu Sathi Scheme at Department of Health and Family Welfare, Purba Bardhaman, Burdwan-713102, West Bengal, India, and the Hon’ble special guest doctor, eminent Senior Consultant Physician & Cardiologist Dr. Tushar Kanti Batabyal, M.B.B.S., M.D., Ex-Clinical Tutor of the Burdwan Medical College & Hospital, Government of West Bengal, India, with the help of; the Hon’ble Secretary, Mr. Rakesh Khan, M.A., B.Ed., (Gold Medalist), and the Hon’ble President, Mr. Subhendu Bose, with all Young Green-Members of the ―International NGO named Burdwan Green Haunter and Students‘ Goal,  the secondary- and higher secondary-students, and the energetic community volunteer. The whole schedule was guided and led by Dr. Subhas Chandra Datta, Headmaster, Secretary, Coordinator, and Researcher of Kanchannagar D.N.Das High School (HS), and the treatment was randomized by using a completely randomized block design and guidance, and the rest of the general sample 100%-communities of Purba Bardhaman District, were treated as ‘Control Treatments Groups (01year to 99 years)’ [9-12], and all the information was counted for statistical analysis by the analysis of variance ‘ANOVA’ (P<0>

General Symptoms 

The observation of main symptoms is fever, cough, tiredness, loss of taste or smell, sore throat, headache, aches, and pains, diarrhea, a rash on the skin, or discoloration of fingers or toes, red or irritated eyes, etc. [9-12,17,19-21]. All the information was counted for statistical analysis by the analysis of variance ‘ANOVA’ (P<0>

Doses of Treatments

The treatments were done @ 10-20 drops of the high-diluted-biomedicine Ginger MT (HDBMGMT), is mixed @ 50ml-100ml (a half to a full cup) of moderately hot sterile-distilled-or pure-drinking-water or tea or milk, orally administered @ 5-8 times/day at an interval of 1- 2hrs, after taking any kinds of nutritious biomedicine-enriched-food against naturally occurring coronavirus infections or re-infections, 45-60 days before symptom onset OR illness onset (as a vaccine) OR onset of symptoms where patients in hospital-associated COVID-19 infections have been reported (treatments), and the dose may be increased depending on the intensity of diseases in case of treatment advised by doctors [9-12,17,19-21]. All the information was counted for statistical analysis by the analysis of variance ‘ANOVA’ (P<0>

Types of Treatments

Four types of treatments; oral, nasal, and vaporized, were followed or applied with HDBMGMT –Soaked-N95-Mask for the ‘Notable-Clinical-Research’ [9-12, 17, 19-21]. 

Oral treatments; were done @ 10-20 drops-HDBMGMT/50ml-100ml (a half to a full cup) drinking-water@ 5-8 times/day at an interval of 1- 2hrs.

Nasal treatments; were collected from ‘oral treatment solution’ and were done @ 1-2 drops-HDBMGMT/nostril@ 5-8 times/day at an interval of 1- 2hrs.

Vaporized treatments; were done @ 10-20 drops-HDBMGMT/100ml-200ml (1-2 full cup) hot-pure-water@ 5-8 times-inhalation/day at an interval of 1- 2hrs.

Medicines-Soaked-N95-Mask; were prepared @ 10-20 drops-HDBMGMT/50ml-100ml pure-water soaked@5-10 mask.

 Data Collection and Records Maintenance

All the data was collected from; the treating doctor, individual, NGO, students, and the different webpage [9-12, 17, 19-21]. The higher secondary (H.S.) students collected data from the communities treatments groups maintaining records of the data for statistical analysis by the analysis of variance ‘ANOVA’ (P<0>

Science Technology Communication Applications (STCA)

The NGO-Burdwan Green Haunter and Students‘Goal with the different communities, scholars, researchers, artists, teachers, staff, community, photographers, different scientists, academicians, clinicians, administrators, institutions, farmers, and media personnel, visited making the news and published in different medical journals [9-12, 17, 19-21].

Protocols 

The school students, NGOs, and different young volunteers organized many social-awareness virtual camps (VC) among the communities in different ways; using masks mandate, cleaning hands with soap, maintaining physical distance, and avoiding touching eyes-nose-mouth, etc. [9-12,17,19-21].

Notable-Clinical-Research-Notes

All the important notes were collected by Dr. Subhas Chandra Datta from the Hon’ble treating doctors of; Dr. Dipanwita Malick, MBBS, and eminent Senior Consultant Physician, Dr. Ranjan Mukherjee, M.B.B.S., M.D., District Coordinator of Sishu Sathi Scheme at Department of Health and Family Welfare, Purba Bardhaman, Burdwan-713102, West Bengal, India, and all the data were also try to clarify by Dr. Subhas Chandra Datta [9-12, 17, 19-21].

Results

Table 1 showed the clinical research notes of high-diluted-biomedicines-Ginger MT as preventive as well as treated biomedicines on family and community against COVID-19 or reinfection;  I-Notable-Clinical-Research- Treatments-Notes-Groups, II-Notable-Clinical-Research-Treatments-Notes-Groups, and III-Nota0ble-Clinical-Research- Treatments-Notes-Groups i.e. average treatment/control age groups (01-99 years) of the different family and communities treatment group’s family members regarding the infection or reinfection of coronavirus 2 / omicron of the families in the community of Burdwan Municipality, Bardhaman-I, and Bardhaman –II, Purba Bardhaman, from March 2020 to December 2021, and all the data were significant difference by the analysis of variance ‘ANOVA’ (P<0>

Figure 1: Covid -19 report of Purba Bardhaman and United States (from Web Pages)

 Potential absolute immunization occurred in all ‘Notable-Clinical-Research- Treatments-Notes-Groups’ due to effective-HDBMGMT and natural immunity. It is noted that the COVID-19 was affected different people in different ways. Most infected people would be developed asymptomatic (57%) or mild to moderate illnesses (21%) and would be recovered 94% without hospitalization (Table 1).

  And in the rest of the general 100%  average control age groups (01-99 years) of the different family and communities group’s family members of Purba Bardhaman District, showed the 92.98% to 93.53% -recovery after hospitalization in comparison with the preventive-HDBMGMT- treatment group within the stipulated time, and all were also counted for statistical analysis by the analysis of variance ‘ANOVA’, where 6.47%  to 7.02% died in aged-and-comorbid, heart-and –diabetic, and COVID 19 patient with asymptomatic or mild to moderate illness and recovered after hospitalization within the same period from March 2020 to December 2021, where the most common symptoms were: fever, cough, tiredness, loss of taste or smell, and the less common symptoms were: sore throat, headache, aches, and pains, diarrhea, a rash on the skin, or discoloration of fingers or toes, red or irritated eyes, following the Covid -19 status of Purba Bardhaman District and United States (Figure 1: from Web Pages). It is interesting that the last Covid-wave is the fastest transmissible and infective but less detrimental in all respect in both preventive-HDBMGMT- treatment/control groups (Table 1).

Notable-Clinical-Research-Notes-Treatments / Control Samples Groups

(01-99 years)

 

Treated and Visited Burdwan Municipality, Burdwan-I & Burdwan-II: March 2020 to December 2021

Average Number of Family 

Average Number of Family Members

Percentage of  COVID-19 Active Patients 

Percentage of  COVID-19 Passive   Patients

Percentage of  Home Quarantine

Percentage of Recovery 

Notable-Clinical-Research-Remarks 

 

I : Notable-Clinical-Research- Treatments-Notes-Groups

 

1208.83a   ±00.03

6044.13ax ±00.11

727.11ay ±13.11 (12%

1450.59bz ±00.11   (24%)

1934.12bz ±00.02 (32%)

5681.48az ±00.16 (94%)

Only 4% mortality of aged-&-co morbid, heart-&-diabetic patient, 2% mortality due to increase effective preventive biomedicines & natural immunity

II : Notable-Clinical-Research- Treatments-Notes-Groups 

751.83b     ±00.01

3007.31bx ±00.17

631.54by ±00.12 (21%)

2375.77az ±00.07   (79%)

2947.16ax ±00.12 (98%)

2766.73bx ±00.11 (92%)

4% died due to heart attack, & only 4%  mortality due to effective preventive  biomedicines

III : Notable-Clinical-Research- Treatments-Notes-Groups

410.40c ±00.02

1231.18cx ±00.02

393.98cy ±00.24 (32%)

837.20cz ±00.22   (68%)

1218.87cx ±00.12 (99%)

1181.93cx ±00.11 (96%)

Died 4% aged-&-co morbid, heart-&-diabetic patient, & no  mortality due to effective preventive biomedicines

Total Average Notable-Clinical-Research-Treatments-Notes-Groups (01-99 years)

 100%

  100%

21.67%

57.01%

76.34%

94% 

Potential 94%   immunization  due to effective biomedicines & natural immunity. And most infected people will develop mild to moderate illness and recover without hospitalization.

Total Average Notable-Clinical-Research-Control-Notes-Groups (01-99 years)

March-2020

100% 

100%

04.87%

75.56%

74.21%

92.98%

Died 7.02%   aged-&-co morbid, heart-&-diabetic, & COVID 19 patient

December-2021

 100%

100%

0.21%

99.79%

88.01%

93.53%

Died 6.47%   aged-&-co morbid, heart-&-diabetic & COVID 19 patient with   mild to moderate illness and recover with hospitalization.

a,b,c’- different small letters in a column, and ‘x,y,z’ different small letters in a row show significant  difference by the analysis of variance ‘ANOVA’ (P<0>

Table 1: 

Clinical research notes of high-diluted-biomédcines-Ginger MT on different community against COVID19

 

Discussion

All the treatments groups of all the age groups on family and community against COVID-19 showed the absolute recovery only in-home quarantine due to treatment with the preventive–HDBMGMT (‘high-diluted-biomedicines-Ginger MT’) on family and community against COVID-19 which contains many active effective phytoconstituents or bioactive compounds, and it provides booster immunity or hard immunity or innate immunity preventing also many diseases; analgesic, diuretic, antifungal, vermifuge, antiulcer, laxative, antiviral, asthma, ulcers, diarrhea, swelling of the mouth or throat, and high cholesterol and hypertension, hepatoprotective and antioxidant activities. For these reasons, all the treatment treatments age groups, 1year to 99 years’ showed more than 96% -absolute recovery only in-home isolation or home quarantines were active or passive infection or reinfection occurred after preventive-–HDBMGMT. And it may develop the blueprint with the help of ‘Students-NGO-Model etc., for potential diagnostics, booster vaccines, and therapeutics against novel coronavirus-2 or omicron or future A to Z disease [9-12, 22-61].

It was remarkable that the highest passive infection/reinfection due to the potential effects of preventive–HDBMGMT. So the potential very old traditional cost-effective side-effect-free environment-friendly easily prepare-able easily-manufacture-able equitable-marketable easily-available and supply-able, the best quality-nanoparticles-biomedical–HDBMGMT at extremely low doses, “From Vaccine-Nationalism-to-Vaccine-Equity— Finding a Path-Forward”, and it will resist COVID vaccine hesitancy against new variants, the ‘Omicron’ that has long been recognized as a problem in high- and middle-income nations of the world’s poorest countries, lack of access to vaccines [62]. And the Ginger MT-biomedicines will be ‘Universal Future Diseases Model’ like “Only wildlife conservation may be future omicron-like-preventive-epidemic-covid-19-model enriched forestry- horticulture-agriculture-environment-health-biodiversity science-technology-communication-application-issues” [63].

So, it confirms the efficacy as-‘Notable-Clinical-Research-Notes’ with the treatment Ginger MT-biomedicines, prepared from the rhizome (Plate 1) of traditional common ginger (Zingiber officinale Rosc.), at extremely low doses, in the different COVID-19- treatments areas; individual, family, and different community, etc. of the Burdwan Municipality, Purba Bardhaman District, West Bengal, India. And it is highlighted novel and significant ideas for the future aspects of the study with the ‘Black Ginger’, the rhizome of Kaempferia parviflora, forming the ‘Notable-Universal-Preventive-Emergency-Vaccine (NUPEV)’ Against 'Future-A to Z-Diseases (FAZD)’ in the ‘New Year 2022’ distributing equally, and preventing shortfalls and global crisis, and oath ourselves “Vaccine equity: there is no time to waste” [18]. 

Conclusion

The ‘Traditional-And-Black-Ginger-Biomedicines (TABGBM)’ May Be Act as ‘Notable-Universal-Preventive-Emergency-Vaccine (NUPEV)’ Against 'Future-A to Z-Diseases (FAZD)’ Enriched ‘Clinical-Case-Reports-Medical-Science-Technology-Communication-Research-Innovation-Global-Health-Ecology-Application (CCRMSTCRIGHEA)”. And in near future, both the Ginger MT-Biomedicines may easily tackle many diseases and complications. I will be ‘NUPEV’ due to medicines formulations, very-low-toxicity, potential efficacy, and different phytochemicals, eco-friendly-side-effects-free, cost-effective, easily prepare-able, easily available, easily-manufacture-able, easily-equitable, easily-marketable and easily-supply-able, etc. And in the future, it will be ‘Policy Initiative Potentially Life-Saving 'Future-A to Z-Vaccine for All’. And in the ‘New Year 2022’ distributing equally, and preventing shortfalls and global crisis, and oath ourselves “Vaccine equity: there is no time to waste”.

Conflict of Interest

The authors declare no conflicts of interest here and the manuscripts is written by the author itself.

Acknowledgement

I am thankful to the eminent educationist Sri Tapaprakash Bhattacharya for inspiration and guidance. I express my deep gratitude to Mr. Rakesh Khan, M.A., B.Ed., (Gold Medalist), Secretary and Mr. Subhendu Bose, President with all Young Green-Members of the ―International NGO named Burdwan Green Haunter and Students‘ Goal‖ for arranging several awareness programmed on COVID-19 with ―Health Care, Biomedicines, Nutritious Food, Vaccination, Agriculture, Biodiversity Conservation and Enriching Science and Technology Communication Economy Application Issues‖. Last but not the least; I am thankful to the eminent Senior Consultant Physician, Dr. Ranjan Mukherjee, M.B.B.S., M.D., District Coordinator, and Dr. Dipanitwa Malik, M.B.B.S. of Sishu Sathi Scheme at Department of Health and Family Welfare, India for inspiration and guidance.

References

Clearly Auctoresonline and particularly Psychology and Mental Health Care Journal is dedicated to improving health care services for individuals and populations. The editorial boards' ability to efficiently recognize and share the global importance of health literacy with a variety of stakeholders. Auctoresonline publishing platform can be used to facilitate of optimal client-based services and should be added to health care professionals' repertoire of evidence-based health care resources.

img

Virginia E. Koenig

Journal of Clinical Cardiology and Cardiovascular Intervention The submission and review process was adequate. However I think that the publication total value should have been enlightened in early fases. Thank you for all.

img

Delcio G Silva Junior

Journal of Women Health Care and Issues By the present mail, I want to say thank to you and tour colleagues for facilitating my published article. Specially thank you for the peer review process, support from the editorial office. I appreciate positively the quality of your journal.

img

Ziemlé Clément Méda

Journal of Clinical Research and Reports I would be very delighted to submit my testimonial regarding the reviewer board and the editorial office. The reviewer board were accurate and helpful regarding any modifications for my manuscript. And the editorial office were very helpful and supportive in contacting and monitoring with any update and offering help. It was my pleasure to contribute with your promising Journal and I am looking forward for more collaboration.

img

Mina Sherif Soliman Georgy

We would like to thank the Journal of Thoracic Disease and Cardiothoracic Surgery because of the services they provided us for our articles. The peer-review process was done in a very excellent time manner, and the opinions of the reviewers helped us to improve our manuscript further. The editorial office had an outstanding correspondence with us and guided us in many ways. During a hard time of the pandemic that is affecting every one of us tremendously, the editorial office helped us make everything easier for publishing scientific work. Hope for a more scientific relationship with your Journal.

img

Layla Shojaie

The peer-review process which consisted high quality queries on the paper. I did answer six reviewers’ questions and comments before the paper was accepted. The support from the editorial office is excellent.

img

Sing-yung Wu

Journal of Neuroscience and Neurological Surgery. I had the experience of publishing a research article recently. The whole process was simple from submission to publication. The reviewers made specific and valuable recommendations and corrections that improved the quality of my publication. I strongly recommend this Journal.

img

Orlando Villarreal

Dr. Katarzyna Byczkowska My testimonial covering: "The peer review process is quick and effective. The support from the editorial office is very professional and friendly. Quality of the Clinical Cardiology and Cardiovascular Interventions is scientific and publishes ground-breaking research on cardiology that is useful for other professionals in the field.

img

Katarzyna Byczkowska

Thank you most sincerely, with regard to the support you have given in relation to the reviewing process and the processing of my article entitled "Large Cell Neuroendocrine Carcinoma of The Prostate Gland: A Review and Update" for publication in your esteemed Journal, Journal of Cancer Research and Cellular Therapeutics". The editorial team has been very supportive.

img

Anthony Kodzo-Grey Venyo

Testimony of Journal of Clinical Otorhinolaryngology: work with your Reviews has been a educational and constructive experience. The editorial office were very helpful and supportive. It was a pleasure to contribute to your Journal.

img

Pedro Marques Gomes

Dr. Bernard Terkimbi Utoo, I am happy to publish my scientific work in Journal of Women Health Care and Issues (JWHCI). The manuscript submission was seamless and peer review process was top notch. I was amazed that 4 reviewers worked on the manuscript which made it a highly technical, standard and excellent quality paper. I appreciate the format and consideration for the APC as well as the speed of publication. It is my pleasure to continue with this scientific relationship with the esteem JWHCI.

img

Bernard Terkimbi Utoo

This is an acknowledgment for peer reviewers, editorial board of Journal of Clinical Research and Reports. They show a lot of consideration for us as publishers for our research article “Evaluation of the different factors associated with side effects of COVID-19 vaccination on medical students, Mutah university, Al-Karak, Jordan”, in a very professional and easy way. This journal is one of outstanding medical journal.

img

Prof Sherif W Mansour

Dear Hao Jiang, to Journal of Nutrition and Food Processing We greatly appreciate the efficient, professional and rapid processing of our paper by your team. If there is anything else we should do, please do not hesitate to let us know. On behalf of my co-authors, we would like to express our great appreciation to editor and reviewers.

img

Hao Jiang

As an author who has recently published in the journal "Brain and Neurological Disorders". I am delighted to provide a testimonial on the peer review process, editorial office support, and the overall quality of the journal. The peer review process at Brain and Neurological Disorders is rigorous and meticulous, ensuring that only high-quality, evidence-based research is published. The reviewers are experts in their fields, and their comments and suggestions were constructive and helped improve the quality of my manuscript. The review process was timely and efficient, with clear communication from the editorial office at each stage. The support from the editorial office was exceptional throughout the entire process. The editorial staff was responsive, professional, and always willing to help. They provided valuable guidance on formatting, structure, and ethical considerations, making the submission process seamless. Moreover, they kept me informed about the status of my manuscript and provided timely updates, which made the process less stressful. The journal Brain and Neurological Disorders is of the highest quality, with a strong focus on publishing cutting-edge research in the field of neurology. The articles published in this journal are well-researched, rigorously peer-reviewed, and written by experts in the field. The journal maintains high standards, ensuring that readers are provided with the most up-to-date and reliable information on brain and neurological disorders. In conclusion, I had a wonderful experience publishing in Brain and Neurological Disorders. The peer review process was thorough, the editorial office provided exceptional support, and the journal's quality is second to none. I would highly recommend this journal to any researcher working in the field of neurology and brain disorders.

img

Dr Shiming Tang

Dear Agrippa Hilda, Journal of Neuroscience and Neurological Surgery, Editorial Coordinator, I trust this message finds you well. I want to extend my appreciation for considering my article for publication in your esteemed journal. I am pleased to provide a testimonial regarding the peer review process and the support received from your editorial office. The peer review process for my paper was carried out in a highly professional and thorough manner. The feedback and comments provided by the authors were constructive and very useful in improving the quality of the manuscript. This rigorous assessment process undoubtedly contributes to the high standards maintained by your journal.

img

Raed Mualem

International Journal of Clinical Case Reports and Reviews. I strongly recommend to consider submitting your work to this high-quality journal. The support and availability of the Editorial staff is outstanding and the review process was both efficient and rigorous.

img

Andreas Filippaios

Thank you very much for publishing my Research Article titled “Comparing Treatment Outcome Of Allergic Rhinitis Patients After Using Fluticasone Nasal Spray And Nasal Douching" in the Journal of Clinical Otorhinolaryngology. As Medical Professionals we are immensely benefited from study of various informative Articles and Papers published in this high quality Journal. I look forward to enriching my knowledge by regular study of the Journal and contribute my future work in the field of ENT through the Journal for use by the medical fraternity. The support from the Editorial office was excellent and very prompt. I also welcome the comments received from the readers of my Research Article.

img

Dr Suramya Dhamija

Dear Erica Kelsey, Editorial Coordinator of Cancer Research and Cellular Therapeutics Our team is very satisfied with the processing of our paper by your journal. That was fast, efficient, rigorous, but without unnecessary complications. We appreciated the very short time between the submission of the paper and its publication on line on your site.

img

Bruno Chauffert

I am very glad to say that the peer review process is very successful and fast and support from the Editorial Office. Therefore, I would like to continue our scientific relationship for a long time. And I especially thank you for your kindly attention towards my article. Have a good day!

img

Baheci Selen

"We recently published an article entitled “Influence of beta-Cyclodextrins upon the Degradation of Carbofuran Derivatives under Alkaline Conditions" in the Journal of “Pesticides and Biofertilizers” to show that the cyclodextrins protect the carbamates increasing their half-life time in the presence of basic conditions This will be very helpful to understand carbofuran behaviour in the analytical, agro-environmental and food areas. We greatly appreciated the interaction with the editor and the editorial team; we were particularly well accompanied during the course of the revision process, since all various steps towards publication were short and without delay".

img

Jesus Simal-Gandara

I would like to express my gratitude towards you process of article review and submission. I found this to be very fair and expedient. Your follow up has been excellent. I have many publications in national and international journal and your process has been one of the best so far. Keep up the great work.

img

Douglas Miyazaki

We are grateful for this opportunity to provide a glowing recommendation to the Journal of Psychiatry and Psychotherapy. We found that the editorial team were very supportive, helpful, kept us abreast of timelines and over all very professional in nature. The peer review process was rigorous, efficient and constructive that really enhanced our article submission. The experience with this journal remains one of our best ever and we look forward to providing future submissions in the near future.

img

Dr Griffith

I am very pleased to serve as EBM of the journal, I hope many years of my experience in stem cells can help the journal from one way or another. As we know, stem cells hold great potential for regenerative medicine, which are mostly used to promote the repair response of diseased, dysfunctional or injured tissue using stem cells or their derivatives. I think Stem Cell Research and Therapeutics International is a great platform to publish and share the understanding towards the biology and translational or clinical application of stem cells.

img

Dr Tong Ming Liu

I would like to give my testimony in the support I have got by the peer review process and to support the editorial office where they were of asset to support young author like me to be encouraged to publish their work in your respected journal and globalize and share knowledge across the globe. I really give my great gratitude to your journal and the peer review including the editorial office.

img

Husain Taha Radhi

I am delighted to publish our manuscript entitled "A Perspective on Cocaine Induced Stroke - Its Mechanisms and Management" in the Journal of Neuroscience and Neurological Surgery. The peer review process, support from the editorial office, and quality of the journal are excellent. The manuscripts published are of high quality and of excellent scientific value. I recommend this journal very much to colleagues.

img

S Munshi

Dr.Tania Muñoz, My experience as researcher and author of a review article in The Journal Clinical Cardiology and Interventions has been very enriching and stimulating. The editorial team is excellent, performs its work with absolute responsibility and delivery. They are proactive, dynamic and receptive to all proposals. Supporting at all times the vast universe of authors who choose them as an option for publication. The team of review specialists, members of the editorial board, are brilliant professionals, with remarkable performance in medical research and scientific methodology. Together they form a frontline team that consolidates the JCCI as a magnificent option for the publication and review of high-level medical articles and broad collective interest. I am honored to be able to share my review article and open to receive all your comments.

img

Tania Munoz

“The peer review process of JPMHC is quick and effective. Authors are benefited by good and professional reviewers with huge experience in the field of psychology and mental health. The support from the editorial office is very professional. People to contact to are friendly and happy to help and assist any query authors might have. Quality of the Journal is scientific and publishes ground-breaking research on mental health that is useful for other professionals in the field”.

img

George Varvatsoulias

Dear editorial department: On behalf of our team, I hereby certify the reliability and superiority of the International Journal of Clinical Case Reports and Reviews in the peer review process, editorial support, and journal quality. Firstly, the peer review process of the International Journal of Clinical Case Reports and Reviews is rigorous, fair, transparent, fast, and of high quality. The editorial department invites experts from relevant fields as anonymous reviewers to review all submitted manuscripts. These experts have rich academic backgrounds and experience, and can accurately evaluate the academic quality, originality, and suitability of manuscripts. The editorial department is committed to ensuring the rigor of the peer review process, while also making every effort to ensure a fast review cycle to meet the needs of authors and the academic community. Secondly, the editorial team of the International Journal of Clinical Case Reports and Reviews is composed of a group of senior scholars and professionals with rich experience and professional knowledge in related fields. The editorial department is committed to assisting authors in improving their manuscripts, ensuring their academic accuracy, clarity, and completeness. Editors actively collaborate with authors, providing useful suggestions and feedback to promote the improvement and development of the manuscript. We believe that the support of the editorial department is one of the key factors in ensuring the quality of the journal. Finally, the International Journal of Clinical Case Reports and Reviews is renowned for its high- quality articles and strict academic standards. The editorial department is committed to publishing innovative and academically valuable research results to promote the development and progress of related fields. The International Journal of Clinical Case Reports and Reviews is reasonably priced and ensures excellent service and quality ratio, allowing authors to obtain high-level academic publishing opportunities in an affordable manner. I hereby solemnly declare that the International Journal of Clinical Case Reports and Reviews has a high level of credibility and superiority in terms of peer review process, editorial support, reasonable fees, and journal quality. Sincerely, Rui Tao.

img

Rui Tao